| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
RESULTS
|
18 |
144.5 |
  |
| 2 |
Marlboro
|
10 |
132.4 |
  |
| 3 |
British American Tobacco
|
10 |
125.1 |
  |
| 4 |
Williamson
|
8 |
118.5 |
  |
| 5 |
Brown
|
8 |
111.6 |
  |
| 6 |
Philip Morris External Research Program
|
7 |
97.9 |
  |
| 7 |
RJ Reynolds
|
7 |
96.0 |
  |
| 8 |
Lorillard
|
6 |
92.6 |
  |
| 9 |
Food and Drug Administration
|
6 |
86.8 |
  |
| 10 |
United States
|
7 |
82.9 |
  |
| 11 |
R.J. Reynolds
|
4 |
63.1 |
  |
| 12 |
METHODS
|
8 |
62.4 |
  |
| 13 |
Thailand
|
5 |
61.7 |
  |
| 14 |
Environmental Protection Agency 's
|
4 |
61.4 |
  |
| 15 |
US
|
6 |
61.1 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
RESULTS
|
18 |
130.4 |
  |
| 2 |
British American Tobacco
|
10 |
117.3 |
  |
| 3 |
Williamson
|
8 |
112.2 |
  |
| 4 |
Brown
|
8 |
105.3 |
  |
| 5 |
Marlboro
|
8 |
100.3 |
  |
| 6 |
Philip Morris External Research Program
|
7 |
92.4 |
  |
| 7 |
Lorillard
|
6 |
87.9 |
  |
| 8 |
Food and Drug Administration
|
6 |
82.1 |
  |
| 9 |
RJ Reynolds
|
6 |
77.4 |
  |
| 10 |
United States
|
7 |
77.4 |
  |
| 11 |
R.J. Reynolds
|
4 |
59.9 |
  |
| 12 |
Environmental Protection Agency 's
|
4 |
58.3 |
  |
| 13 |
Thailand
|
5 |
57.8 |
  |
| 14 |
Chulabhorn Research Institute
|
4 |
57.2 |
  |
| 15 |
Ernst Wynder
|
4 |
57.0 |
  |
|
| 365 days (2008-12-20 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Chulabhorn Research Institute
|
4 |
45.1 |
  |
| 2 |
American Legacy Foundation
|
2 |
24.4 |
  |
| 3 |
Thailand
|
2 |
21.8 |
  |
| 4 |
Transnational tobacco companies
|
1 |
12.9 |
  |
| 5 |
Ecuadorian
|
1 |
12.5 |
  |
| 6 |
TEKEL
|
1 |
12.5 |
  |
| 7 |
British American Tobacco
|
1 |
12.2 |
  |
| 8 |
Roger Walk
|
1 |
12.0 |
  |
| 9 |
Thai
|
1 |
12.0 |
  |
| 10 |
Framework Convention on Tobacco Control
|
1 |
11.6 |
  |
| 11 |
Philip Morris Nordic
|
1 |
11.5 |
  |
| 12 |
Asia
|
1 |
10.4 |
  |
| 13 |
BACKGROUND
|
1 |
10.4 |
  |
| 14 |
Turkey
|
1 |
8.9 |
  |
| 15 |
CONCLUSIONS
|
1 |
5.2 |
  |
|